Ruth Duncan

Overview

Best Publications

• The dawning era of polymer therapeutics

  Ruth Duncan

  4898
  Citations

• Polymer conjugates as anticancer nanomedicines

  Ruth Duncan

  2832
  Citations

• Dendrimer biocompatibility and toxicity.

  Unknown

  1610
  Citations

• Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.

  N Malik;R Wiwattanapatapee;R Klopsch;K Lorenz

  1590
  Citations

• Nanomedicine(s) under the Microscope

  Unknown

  1175
  Citations

• Phase I Clinical and Pharmacokinetic Study of PK1 [N-(2-Hydroxypropyl)methacrylamide Copolymer Doxorubicin]: First Member of a New Class of Chemotherapeutic Agents—Drug-Polymer Conjugates

  Paul A. Vasey;Stan B. Kaye;Rosemary Morrison;Chris Twelves

  1094
  Citations

• Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA

  SimonC.W. Richardson;HannoV.J. Kolbe;Ruth Duncan

  757
  Citations

• Drug-polymer conjugates: potential for improved chemotherapy.

  Unknown

  657
  Citations

• Dendrimer-platinate: a novel approach to cancer chemotherapy.

  Navid Malik;Evagoras G Evagorou;Ruth Duncan

  656
  Citations

• Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats.

  L. W. Seymour;R. Duncan;J. Strohalm;Jindrich Kopecek

  615
  Citations

• Early Phase Tumor Accumulation of Macromolecules: A Great Difference in Clearance Rate between Tumor and Normal Tissues

  Youichiro Noguchi;Jun Wu;Ruth Duncan;Jiří Strohalm

  606
  Citations

• Polymer conjugates: nanosized medicines for treating cancer

  María J. Vicent;Ruth Duncan

  599
  Citations

• Highly cited research articles in Journal of Controlled Release: Commentaries and perspectives by authors

  Nicholas A. Peppas;Ruth Duncan;Gary E. Wnek;Allan S. Hoffman

  537
  Citations

• Polymer therapeutics-prospects for 21st century: the end of the beginning.

  Ruth Duncan;María J. Vicent

  486
  Citations

• Soluble synthetic polymers as potential drug carriers

  Ruth Duncan;Jindřich Kopeček

  481
  Citations

• INFLUENCE OF MOLECULAR WEIGHT ON PASSIVE TUMOUR ACCUMULATION OF A SOLUBLE MACROMOLECULAR DRUG CARRIER

  L.W. Seymour;Y. Miyamoto;H. Maeda;M. Brereton

  461
  Citations

• PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity.

  Francesco M Veronese;Oddone Schiavon;Gianfranco Pasut;Raniero Mendichi

  444
  Citations

• Evaluation of the biological properties of soluble chitosan and chitosan microspheres

  Begoña Carreño-Gómez;Ruth Duncan

  444
  Citations

• Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation

  Sunil Shaunak;Sharyn Thomas;Elisabetta Gianasi;Antony Godwin

  390
  Citations

• Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: opportunities and challenges.

  Unknown

  384
  Citations

• Development of HPMA copolymer–anticancer conjugates: Clinical experience and lessons learnt

  Ruth Duncan

  357
  Citations

• Methods for the evaluation of biocompatibility of soluble synthetic polymers which have potential for biomedical use: 1 - Use of the tetrazolium-based colorimetric assay (MTT) as a preliminary screen for evaluation of in vitro cytotoxicity

  D. Sgouras;R. Duncan

  347
  Citations

• Polymer therapeutics: polymers as drugs, drug and protein conjugates and gene delivery systems : Past, present and future opportunities

  Ruth Duncan;Helmut Ringsdorf;Ronit Satchi-Fainaro

  338
  Citations

• Anionic PAMAM Dendrimers Rapidly Cross Adult Rat Intestine In Vitro: A Potential Oral Delivery System?

  Ruedeekorn Wiwattanapatapee;Begoña Carreño-Gómez;Navid Malik;Ruth Duncan

  319
  Citations